vs
Side-by-side financial comparison of HAEMONETICS CORP (HAE) and Limbach Holdings, Inc. (LMB). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($339.0M vs $186.9M, roughly 1.8× Limbach Holdings, Inc.). HAEMONETICS CORP runs the higher net margin — 13.2% vs 6.6%, a 6.6% gap on every dollar of revenue. On growth, Limbach Holdings, Inc. posted the faster year-over-year revenue change (30.1% vs -2.7%). HAEMONETICS CORP produced more free cash flow last quarter ($87.2M vs $27.9M). Over the past eight quarters, Limbach Holdings, Inc.'s revenue compounded faster (25.3% CAGR vs 0.4%).
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
Limbach Flugmotoren is a Chinese-owned company based in Germany that produces aircraft engines.
HAE vs LMB — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $339.0M | $186.9M |
| Net Profit | $44.7M | $12.3M |
| Gross Margin | 59.7% | 25.7% |
| Operating Margin | 19.9% | 9.4% |
| Net Margin | 13.2% | 6.6% |
| Revenue YoY | -2.7% | 30.1% |
| Net Profit YoY | 19.3% | 25.0% |
| EPS (diluted) | $0.95 | $1.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $339.0M | $186.9M | ||
| Q3 25 | $327.3M | $184.6M | ||
| Q2 25 | $321.4M | $142.2M | ||
| Q1 25 | $330.6M | $133.1M | ||
| Q4 24 | $348.5M | $143.7M | ||
| Q3 24 | $345.5M | $133.9M | ||
| Q2 24 | $336.2M | $122.2M | ||
| Q1 24 | — | $119.0M |
| Q4 25 | $44.7M | $12.3M | ||
| Q3 25 | $38.7M | $8.8M | ||
| Q2 25 | $34.0M | $7.8M | ||
| Q1 25 | $58.0M | $10.2M | ||
| Q4 24 | $37.5M | $9.8M | ||
| Q3 24 | $33.8M | $7.5M | ||
| Q2 24 | $38.4M | $6.0M | ||
| Q1 24 | — | $7.6M |
| Q4 25 | 59.7% | 25.7% | ||
| Q3 25 | 59.5% | 24.2% | ||
| Q2 25 | 59.8% | 28.0% | ||
| Q1 25 | 58.4% | 27.6% | ||
| Q4 24 | 55.5% | 30.3% | ||
| Q3 24 | 54.2% | 27.0% | ||
| Q2 24 | 52.0% | 27.4% | ||
| Q1 24 | — | 26.1% |
| Q4 25 | 19.9% | 9.4% | ||
| Q3 25 | 17.9% | 7.2% | ||
| Q2 25 | 16.8% | 7.5% | ||
| Q1 25 | 21.6% | 5.9% | ||
| Q4 24 | 16.9% | 9.1% | ||
| Q3 24 | 15.0% | 8.1% | ||
| Q2 24 | 11.8% | 6.7% | ||
| Q1 24 | — | 5.5% |
| Q4 25 | 13.2% | 6.6% | ||
| Q3 25 | 11.8% | 4.8% | ||
| Q2 25 | 10.6% | 5.5% | ||
| Q1 25 | 17.5% | 7.7% | ||
| Q4 24 | 10.8% | 6.9% | ||
| Q3 24 | 9.8% | 5.6% | ||
| Q2 24 | 11.4% | 4.9% | ||
| Q1 24 | — | 6.4% |
| Q4 25 | $0.95 | $1.01 | ||
| Q3 25 | $0.81 | $0.73 | ||
| Q2 25 | $0.70 | $0.64 | ||
| Q1 25 | $1.17 | $0.85 | ||
| Q4 24 | $0.74 | $0.81 | ||
| Q3 24 | $0.66 | $0.62 | ||
| Q2 24 | $0.74 | $0.50 | ||
| Q1 24 | — | $0.64 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $363.4M | $11.3M |
| Total DebtLower is stronger | $1.2B | $30.5M |
| Stockholders' EquityBook value | $911.5M | $195.7M |
| Total Assets | $2.5B | $381.1M |
| Debt / EquityLower = less leverage | 1.34× | 0.16× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $363.4M | $11.3M | ||
| Q3 25 | $296.4M | $9.8M | ||
| Q2 25 | $292.9M | $38.9M | ||
| Q1 25 | $306.8M | $38.1M | ||
| Q4 24 | $320.8M | $44.9M | ||
| Q3 24 | $299.3M | $51.2M | ||
| Q2 24 | $344.4M | $59.5M | ||
| Q1 24 | — | $48.2M |
| Q4 25 | $1.2B | $30.5M | ||
| Q3 25 | $1.2B | $56.3M | ||
| Q2 25 | $1.2B | $28.4M | ||
| Q1 25 | $1.2B | $23.7M | ||
| Q4 24 | — | $23.6M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $19.7M | ||
| Q1 24 | — | $19.4M |
| Q4 25 | $911.5M | $195.7M | ||
| Q3 25 | $849.2M | $181.6M | ||
| Q2 25 | $882.3M | $170.5M | ||
| Q1 25 | $820.8M | $161.1M | ||
| Q4 24 | $906.9M | $153.5M | ||
| Q3 24 | $878.9M | $142.2M | ||
| Q2 24 | $905.4M | $133.0M | ||
| Q1 24 | — | $125.5M |
| Q4 25 | $2.5B | $381.1M | ||
| Q3 25 | $2.4B | $409.1M | ||
| Q2 25 | $2.5B | $343.0M | ||
| Q1 25 | $2.5B | $336.4M | ||
| Q4 24 | $2.5B | $352.1M | ||
| Q3 24 | $2.5B | $324.4M | ||
| Q2 24 | $2.5B | $303.9M | ||
| Q1 24 | — | $289.2M |
| Q4 25 | 1.34× | 0.16× | ||
| Q3 25 | 1.44× | 0.31× | ||
| Q2 25 | 1.39× | 0.17× | ||
| Q1 25 | 1.49× | 0.15× | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $93.6M | $28.1M |
| Free Cash FlowOCF − Capex | $87.2M | $27.9M |
| FCF MarginFCF / Revenue | 25.7% | 14.9% |
| Capex IntensityCapex / Revenue | 1.9% | 0.1% |
| Cash ConversionOCF / Net Profit | 2.09× | 2.29× |
| TTM Free Cash FlowTrailing 4 quarters | $308.1M | $41.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.6M | $28.1M | ||
| Q3 25 | $111.3M | $13.3M | ||
| Q2 25 | $17.4M | $2.0M | ||
| Q1 25 | $116.6M | $2.2M | ||
| Q4 24 | $43.8M | $19.3M | ||
| Q3 24 | $48.8M | $4.9M | ||
| Q2 24 | $-27.4M | $16.5M | ||
| Q1 24 | — | $-3.9M |
| Q4 25 | $87.2M | $27.9M | ||
| Q3 25 | $106.3M | $12.8M | ||
| Q2 25 | $13.6M | $1.2M | ||
| Q1 25 | $100.9M | $11.0K | ||
| Q4 24 | $35.2M | $18.0M | ||
| Q3 24 | $39.4M | $4.6M | ||
| Q2 24 | $-33.1M | $13.2M | ||
| Q1 24 | — | $-6.5M |
| Q4 25 | 25.7% | 14.9% | ||
| Q3 25 | 32.5% | 7.0% | ||
| Q2 25 | 4.2% | 0.8% | ||
| Q1 25 | 30.5% | 0.0% | ||
| Q4 24 | 10.1% | 12.5% | ||
| Q3 24 | 11.4% | 3.4% | ||
| Q2 24 | -9.8% | 10.8% | ||
| Q1 24 | — | -5.5% |
| Q4 25 | 1.9% | 0.1% | ||
| Q3 25 | 1.5% | 0.3% | ||
| Q2 25 | 1.2% | 0.6% | ||
| Q1 25 | 4.7% | 1.7% | ||
| Q4 24 | 2.5% | 0.9% | ||
| Q3 24 | 2.7% | 0.3% | ||
| Q2 24 | 1.7% | 2.7% | ||
| Q1 24 | — | 2.1% |
| Q4 25 | 2.09× | 2.29× | ||
| Q3 25 | 2.88× | 1.52× | ||
| Q2 25 | 0.51× | 0.26× | ||
| Q1 25 | 2.01× | 0.22× | ||
| Q4 24 | 1.17× | 1.96× | ||
| Q3 24 | 1.44× | 0.66× | ||
| Q2 24 | -0.71× | 2.77× | ||
| Q1 24 | — | -0.52× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
LMB
| Owner Direct Relationships Segment | $145.0M | 78% |
| General Contractor Construction Manager Relationships Segment | $41.9M | 22% |
